By Professor Anne Margaret Keogh

Journal articles

Allada CS; Keogh AM; Kotlyar E; Hayward CS; Macdonald PS, 2002, 'Efficacy, tolerability, and long-term effects of carvedilol in women', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 39, pp. 195A - 195A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000174106700867&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rose ML; Smith J; Dureau G; Keogh A; Kobashigowa J, 2002, 'Mycophenolate mofetil decreases antibody production after cardiac transplantation', Journal of Heart and Lung Transplantation, 21, pp. 282 - 285, http://dx.doi.org/10.1016/S1053-2498(01)00335-7

Tedoriya T; Keogh AM; Kusano K; Savdie E; Hayward C; Spratt PM; Wilson M; Macdonald PS, 2002, 'Reversal of chronic cyclosporine nephrotoxicity after heart transplantation - Potential role of mycophenolate mofetil', Journal of Heart and Lung Transplantation, 21, pp. 976 - 982, http://dx.doi.org/10.1016/S1053-2498(02)00422-9

Keogh AM; Macefield J, 2002, 'The use of clinical reasoning to promote patient choice', EDTNA-ERCA Journal, 28, pp. 151 - 152, http://dx.doi.org/10.1111/j.1755-6686.2002.tb00231.x

Keogh A; Ten Y; Eugene K, 2002, 'Effects of inhaled Iloprost in severe pulmonary arterial hypertension (PAH) of varied etiology', The Journal of Heart and Lung Transplantation, 21, pp. 65 - 66, http://dx.doi.org/10.1016/s1053-2498(01)00465-x

Keogh AM; Brown KM; Corrigan CA; Allada C; Ten Y, 2002, 'The effect of open label UT15 or bosentan on hospitalisation days in patients with pulmonary arterial hypertension (PAH)', The Journal of Heart and Lung Transplantation, 21, pp. 159 - 159, http://dx.doi.org/10.1016/s1053-2498(01)00723-9

Hayward CS; Macdonald PS; Keogh AM, 2001, 'Inhaled nitric oxide in cardiology', Expert Opinion on Investigational Drugs, 10, pp. 1947 - 1956, http://dx.doi.org/10.1517/13543784.10.11.1947

Cooper DKC; Keogh AM, 2001, 'The potential role of xenotransplantation in treating endstage cardiac disease: A summary of the report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation', Current Opinion in Cardiology, 16, pp. 105 - 109, http://dx.doi.org/10.1097/00001573-200103000-00005

Harris KPG; Keogh AM; Alderson L, 2001, 'Peritoneal dialysis fill volume: Can the patient tell the difference?', Peritoneal Dialysis International, 21, http://dx.doi.org/10.1177/089686080102103s24

Keogh A; Dealey C, 2001, 'Profiling beds versus standard hospital beds: effects on pressure ulcer incidence outcomes.', Journal of wound care, 10, pp. 15 - 19, http://dx.doi.org/10.12968/jowc.2001.10.2.26049

Keogh AM; Arnold RH; Macdonald PS; Hawkins RC; Morgan GW; Spratt P, 2001, 'A randomized trial of tacrolimus (FK506) versus total lymphoid irradiation for the control of repetitive rejection after cardiac transplantation', Journal of Heart and Lung Transplantation, 20, pp. 1331 - 1334

Berry DA; Keogh AM; dos Remedios CG, 2001, 'Nuclear membrane proteins in failing human dilated cardiomyopathy', Proteomics, 1, pp. 1507 - 1512

Kotlyar E; Macdonald PS; Keogh AM; Arnold RH; McCaffrey DJ; Wilson MK; Spratt P, 2001, 'Optimization of left ventricular function with carvedilol before high-risk cardiac surgery', Journal of Heart and Lung Transplantation, 20, pp. 1129 - 1131

Akhlaghi F; Keogh AM; McLachlan AJ; Kaan A, 2001, 'Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors', Journal of Heart and Lung Transplantation, 20, pp. 431 - 438

Henderson NK; Eisman JA; Keogh AM; Macdonald PS; Glanville AR; Spratt P; Sambrook PN, 2001, 'Protective effect of short-term calcitriol or cyclical eitronate on bone loss after cardiac or lung transplantation', Journal of Bone and Mineral Research, 16, pp. 565 - 571

Tedoriya T; MacDonald PS; Keogh AM; Wilson M; Spratt PM, 2001, 'Reversal of chronic cyclosporin nephrotoxicity after heart transplantation.', J Heart Lung Transplant, 20, pp. 247 - 248, http://dx.doi.org/10.1016/s1053-2498(00)00562-3

Wild D; Grove A; Keogh A; Farina C, 2000, 'Assessing quality of life in routine clinical practice: A pilot study', EDTNA-ERCA Journal, 26, pp. 27 - 30, http://dx.doi.org/10.1016/S1098-3015(11)70552-6

Depczynski B; Daly B; Campbell LV; Chisholm DJ; Keogh A, 2000, 'Author's response to the letter 'predicting the occurrence of diabetes mellitus in recipients of heart transplants' [2]', Diabetic Medicine, 17, pp. 624, http://dx.doi.org/10.1046/j.1464-5491.2000.00331-2.x

Berry DA; Balcar VJ; Barden JA; Keogh A; Dos Remedios CG, 2000, 'Determination of P2X1α-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles', Electrophoresis, 21, pp. 3857 - 3862, http://dx.doi.org/10.1002/1522-2683(200011)21:17<3857::AID-ELPS3857>3.0.CO;2-R

Keogh AM; Pope J; Anthony I; Arnell-Cullen V; Hamilton M, 2000, 'Perceptions of renal nursing', EDTNA-ERCA Journal, 26, pp. 44 - 46, http://dx.doi.org/10.1111/j.1755-6686.2000.tb00104.x

Sambrook PN; Henderson K; Keogh AM; Mcdonald PS; Glanville AR; Spratt PM; Bergin P; Ebeling P; Eisman JA, 2000, 'Effect of calcitriol on bone loss after cardiac or lung transplantation', Journal of Bone and Mineral Research, 15, pp. 1818 - 1824

Keogh AM; Mcdonald PS; Aboyoun C; Spratt PM; Mundy J, 2000, 'Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation', Journal of Heart and Lung Transplantation, 19, pp. 529 - 537

Williamson DJ; Wallman LL; Jones R; Keogh AM; Scroope F; Penny R; Weber C; Mcdonald PS, 2000, 'Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmunory hypertension', Circulation, 102, pp. 411 - 418

Weston LE; Sullivan JS; Keogh AM; Geczy AF, 2000, 'Interleukin-2-producing helper T lymphocyte precursor frequency and rejection: a longitudinal cellular study after cardiac transplantation', Immunology and Cell Biology, pp. 272 - 279

Weston LE; Sullivan JS; Keogh AM; Geczy AF, 2000, 'Interleukin-2-producing helper T lymphocyte precursor frequency and rejection: a longitudinal cellular study after cardiac transplantation', Immunology and Cell Biology, pp. 272 - 279

Depczynski B; Daly B; Campbell LV; Chisholm DJ; Keogh AM, 2000, 'Predicting the occurrence of diabetes mellitus in recipients of heart transplants', Diabetic Medicine, 17, pp. 15 - 19

Hughes MJ; Kleinert S; Keogh AM; Mcdonald PS; Wilkinson JG; Weintraub R, 2000, 'Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy', Journal of Heart and Lung Transplantation, 19, pp. 701 - 704

Cooper DA; Keogh AM; Brink J; Corris P; Klepetko W; Pierson R; Schmoeckel M; Shirakura R; Stevenson LW, 2000, 'Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: The present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulm', Journal of Heart and Lung Transplantation, 19, pp. 1125 - 1165

Keogh AM; Feehally J, 1999, 'A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy.', ANNA journal / American Nephrology Nurses' Association, 26

Keogh A, 1999, 'Teamwork and the renal nurse.', Nursing times, 95, pp. 52 - 54

Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper S; Morgan GW, 1999, 'Aggressive cutaneous malignancies following cardiothoracic transplantation', Cancer, pp. 1758 - 1764

Akhlaghi F; Ashley J; Keogh AM; Brown KM, 1999, 'Cyclosporine plasma unbound fraction in heart and lung transplantation recipients', Therapeutic Drug Monitoring, 21, pp. 8 - 16

Nand RA; McLachlan AJ; Keogh AM; Brown KF, 1999, 'DISTRIBUTION OF TACROLIMUS IN BLOOD.', Therapeutic Drug Monitoring, 21, pp. 444 - 444, http://dx.doi.org/10.1097/00007691-199908000-00071

Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; Mccaffrey D, 1999, 'Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure', Heart, pp. 589 - 593

Ong CS; Keogh AM; Kossard S; Macdonald PS; Spratt PM, 1999, 'Skin cancer in Australian heart transplant recipients', Journal of the American Academy of Dermatology, pp. 27 - 34

McLachlan AJ; Keogh AM; Nand RA, 1999, 'TACROLIMUS DRUG INTERACTIONS IN CARDIOTHORACIC TRANSPLANT RECIPIENTS.', Therapeutic Drug Monitoring, 21, pp. 441 - 441, http://dx.doi.org/10.1097/00007691-199908000-00060

Eisen H; Bourge R; Costanzo M; Dureau G; Keogh A; Kobashigawa J; Mamelok R; Mehra M; Mentzer R; Miller L; Renlund D; Smart F; Valantine H, 1999, 'Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial', Transplantation, 67, pp. S543 - S543, http://dx.doi.org/10.1097/00007890-199905150-00026

Eisen H; Bourge R; Costanzo M; Dureau G; Keogh A; Kobashigawa J; Mamelok R; Mehra M; Mentzer R; Miller L; Renlund D; Smart F; Valantine H, 1999, 'Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial', Transplantation, 67, pp. S268 - S268, http://dx.doi.org/10.1097/00007890-199904150-01071

Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; Mccaffrey D, 1999, 'Tolerability and efficacy of carvediolol in patients with New York Heart Association Class IV heart failure', Journal of the American College of Cardiology, pp. 924 - 931

Akhlaghi F; Keogh AM; Brown KM, 1999, 'Unbound cyclosporine and allograft rejection after heart transplantation', Transplantation, pp. 54 - 59

Sindone AP; Sammel NL; Keech AC; Macdonald PS; Keogh AM, 1998, 'Exercise training improves symptoms, exercise capacity and neurohumoral abnormalities in moderate to severe heart failure', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 31, pp. 509A - 509A, http://dx.doi.org/10.1016/S0735-1097(97)88216-2

Uebaba K; Xu F; Takebe M; Takayanagi H; Shibata H; Ishiyama H; Amano K; Sindone AP; O'Rourke MF; Keogh AM, 1998, 'GTN induced changes of circulatory parameters calculated from radial pulse pressure contours in cardiomyopathic patients', Japanese Journal of Clinical Pharmacology and Therapeutics, 29, pp. 115 - 116, http://dx.doi.org/10.3999/jscpt.29.115

Kobashigawa J; Miller L; Renlund D; Mentzer R; Keogh AM, 1998, 'A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients', Transplantation, pp. 507 - 515

Macdonald PS; Keogh AM; Mundy J; Rogers PL; Nicholson A; Harrison GA; Jansz P; Kaan A; Spratt PM, 1998, 'Adjunctive use of inhaled nitric oxide during implantation of a left ventricular assist device', Journal of Heart and Lung Transplantation, 17, pp. 312 - 316

Berry D; Yao M; Barden J; Balcar VJ; Hansen MA; Bennett MJ; Keogh AM; Dos Remedios C, 1998, 'Alterations in the expression of P2X1 receptors in failing and nondiseased human atria', Electrophoresis, 19, pp. 1 - 4

Keogh AM, 1998, 'Dilatrend improves the outlook for CHF', Australian JournalPharmacy, pp. 1228 - 1229

Sindone AP; Sammel NL; Keech AC; Macdonald PS; Keogh AM, 1998, 'Exercise training improves symptoms, exercise capacity and neurohumoral abnormalities in moderate to severe heart failure', Journal of the American College of Cardiology, 31, pp. 509 - 509, http://dx.doi.org/10.1016/s0735-1097(98)80567-6

Akhlaghi F; Ashley J; Keogh AM; Brown KM, 1998, 'Indirect estimation of the unbound fraction of cyclosporine in plasma', Therapeutic Drug Monitoring, 20, pp. 301 - 308

Ng P; Mccluskey P; Mccaughan GW; Glanville AR; Macdonald PS; Keogh AM, 1998, 'Ocular complications of heart, lung, and liver transplantation', British Journal of Ophthalmology, pp. 423 - 428

Sindone AP; Macdonald PS; Keogh AM, 1997, 'Relationship between the walk tests and height, weight and body surface area in advanced heart failure', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29, pp. 96668 - 96668, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WF76100693&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page